Table 1 The clinico-pathological characteristics of patients with primary operable invasive ductal breast cancer (n=379)

From: Comparison of Visual and automated assessment of Ki-67 proliferative activity and their impact on outcome in primary operable invasive ductal breast cancer

Clinico-pathological characteristics

Patients ( n)

Age (⩽50/>50 years)

117 (31%)/262 (69%)

Size (⩽20/21–50/>50 mm)

219 (58%)/149 (39%)/11 (3%)

Grade (I/II/III)

59 (16%)/143 (38%)/177 (47%)

Involved lymph node (0/1–3/>3)

207 (55%)/106 (28%)/63 (17%)

Oestrogen receptor status (ER−/ER+)

148 (39%)/225 (59%)

Progesterone receptor status (PR−/PR+)

208 (55%)/168 (44%)

HER-2 status (HER-2−/HER-2+)

300 (79%)/71 (19%)

Ki-67 (low/high)

272 (72%)/107 (28%)

Loco-regional treatment (Lumpectomy+radiotherapy/mastectomy+radiotherapy)

153 (40%)/226 (60%)

Systemic treatment (ER-based treatment) (hormonal/hormonal+chemotherapy/chemotherapy/none)

184 (49%)/77 (20%)/95 (25%)/18 (5%)

Back to article page